Cargando…

Identification of Lactate as a Cardiac Protectant by Inhibiting Inflammation and Cardiac Hypertrophy Using a Zebrafish Acute Heart Failure Model

Acute heart failure (AHF) commonly arises from decompensated chronic heart failure or sudden structural and functional breakdown causing a decrease in cardiac contractility and consequently fluid accumulation and systemic congestion. Current treatment for AHF aims at reducing fluid overload and impr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haege, Elijah R., Huang, Hui-Chi, Huang, Cheng-chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999541/ https://www.ncbi.nlm.nih.gov/pubmed/33803943 http://dx.doi.org/10.3390/ph14030261

Ejemplares similares

Epigenetics in Cardiac Hypertrophy and Heart Failure
por: Liu, Chia-Feng, et al.
Publicado: (2019)

Glucose Metabolism in Cardiac Hypertrophy and Heart Failure
por: Tran, Diem H., et al.
Publicado: (2019)

Noncoding RNAs in Cardiac Hypertrophy and Heart Failure
por: Lu, Peilei, et al.
Publicado: (2022)

Cardiac Hypertrophy Involves Both Myocyte Hypertrophy and Hyperplasia in Anemic Zebrafish
por: Sun, Xiaojing, et al.
Publicado: (2009)

Cardiac‐specific ablation of glutaredoxin 3 leads to cardiac hypertrophy and heart failure
por: Donelson, Jimmonique, et al.
Publicado: (2019)

Protective Effects of Thyroid Hormone Deprivation on Progression of Maladaptive Cardiac Hypertrophy and Heart Failure
por: Kerp, Helena, et al.
Publicado: (2021)

Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart Failure
por: Yan, Youchen, et al.
Publicado: (2022)

Inhalation of diesel exhaust does not exacerbate cardiac hypertrophy or heart failure in two mouse models of cardiac hypertrophy
por: Liu, Yonggang, et al.
Publicado: (2013)

Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure
por: Gogiraju, Rajinikanth, et al.
Publicado: (2019)

Role of Irisin in Myocardial Infarction, Heart Failure, and Cardiac Hypertrophy
por: Ho, Ming-Yun, et al.
Publicado: (2021)

Roles of histone acetylation sites in cardiac hypertrophy and heart failure
por: Funamoto, Masafumi, et al.
Publicado: (2023)

Identification of TGF-β-related genes in cardiac hypertrophy and heart failure based on single cell RNA sequencing
por: Huang, Kai, et al.
Publicado: (2023)

AAV-mediated expression of NFAT decoy oligonucleotides protects from cardiac hypertrophy and heart failure
por: Remes, Anca, et al.
Publicado: (2021)

Slowing Heart Rate Protects Against Pathological Cardiac Hypertrophy
por: Sebastian, Sonia, et al.
Publicado: (2022)

Identification of Potentially Relevant Genes for Excessive Exercise-Induced Pathological Cardiac Hypertrophy in Zebrafish
por: Zhou, Zuoqiong, et al.
Publicado: (2020)

Brain Renin–Angiotensin System in Hypertension, Cardiac Hypertrophy, and Heart Failure
por: Campos, Luciana Aparecida, et al.
Publicado: (2012)

Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease
por: Baccam, Gabriel C., et al.
Publicado: (2022)

Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis
por: Chen, Yan, et al.
Publicado: (2022)

Cardiac nuclear high mobility group box 1 prevents the development of cardiac hypertrophy and heart failure
por: Funayama, Akira, et al.
Publicado: (2013)

TIP30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation
por: Grund, Andrea, et al.
Publicado: (2019)

β-AR Blockers Suppresses ER Stress in Cardiac Hypertrophy and Heart Failure
por: Ni, Li, et al.
Publicado: (2011)

Aberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure
por: Nagai-Okatani, Chiaki, et al.
Publicado: (2016)

Early dystrophin loss is coincident with the transition of compensated cardiac hypertrophy to heart failure
por: Prado, Fernanda P., et al.
Publicado: (2017)

Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure
por: Shah, Anureet K., et al.
Publicado: (2021)

Echocardiographic markers of cardiac amyloidosis in patients with heart failure and left ventricular hypertrophy
por: Polo, Jorge Melero, et al.
Publicado: (2023)

Impact of polyphenols on heart failure and cardiac hypertrophy: clinical effects and molecular mechanisms
por: Hedayati, Neda, et al.
Publicado: (2023)

SIRT2 inhibition protects against cardiac hypertrophy and ischemic injury
por: Yang, Xiaoyan, et al.
Publicado: (2023)

IL-12α deficiency attenuates pressure overload-induced cardiac inflammation, hypertrophy, dysfunction, and heart failure progression
por: Bhattarai, Umesh, et al.
Publicado: (2023)

A personalized, multiomics approach identifies genes involved in cardiac hypertrophy and heart failure
por: Santolini, Marc, et al.
Publicado: (2018)

Loss of Akap1 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure
por: Schiattarella, Gabriele G., et al.
Publicado: (2018)

Role and mechanism of cardiac insulin resistance in occurrence of heart failure caused by myocardial hypertrophy
por: Zheng, Liling, et al.
Publicado: (2019)

KLF2 regulates neutrophil activation and thrombosis in cardiac hypertrophy and heart failure progression
por: Tang, Xinmiao, et al.
Publicado: (2022)

CCL17 acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure
por: Zhang, Yang, et al.
Publicado: (2022)

Cardiac Hypertrophy
por: DaCosta,
Publicado: (1891)

Knockout of the ATPase inhibitory factor 1 protects the heart from pressure overload-induced cardiac hypertrophy
por: Yang, Kevin, et al.
Publicado: (2017)

KR-39038, a Novel GRK5 Inhibitor, Attenuates Cardiac Hypertrophy and Improves Cardiac Function in Heart Failure
por: Lee, Jeong Hyun, et al.
Publicado: (2020)

Disease progression in cardiac morphology and function in heart failure: ATTR cardiac amyloidosis versus hypertensive left ventricular hypertrophy
por: Henein, M. Y., et al.
Publicado: (2022)

Moderate exercise training attenuates aging-induced cardiac inflammation, hypertrophy and fibrosis injuries of rat hearts
por: Liao, Po-Hsiang, et al.
Publicado: (2015)

Oridonin protects against cardiac hypertrophy by promoting P21-related autophagy
por: Xu, Man, et al.
Publicado: (2019)

Inflammation and resolution signaling in cardiac repair and heart failure
por: Halade, Ganesh V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jqts06v4fhu5k117ucunt771qd